San Diego, CA, United States of America

Martin Keller

This inventor holds 22 USPTO granted patents and 2 published patent applications, plus 2 CIPO patents and 3 EPO patents, primarily in Catalytic Conversion. Top assignees: Diversa Corporation, Ut-Battelle, Inc., Tenneco Automotive Operating Company Inc.. Active years: 1978-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Martin Keller. Retrieved from https://idiyas.com/inventor/martin-keller-1lz72qlk

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 22 

% Patents Active = 90.9



Average Co-Inventor Count = 1.9

ph-index = 8

Forward Citations = 324(Granted Patents)


Location History:

  • Golden, CO (US) (1978 - 1999)
  • San Diego, CA (US) (2001 - 2005)
  • Fairfax, VA (US) (2012)
  • Toledo, OH (US) (2012)
  • Indian Trail, NC (US) (2015)
  • Kill Devil Hills, NC (US) (2017)
  • Knoxville, TN (US) (2016 - 2023)

Company Filing History:


Years Active: 1978-2025

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Zeolitic Catalytic Conversion
Hydrocarbons
Air Filtration
Toxic Gas Removal
Enzyme Screening
High Throughput Screening
Microbial Enrichment
Capillary Array
22 patents (USPTO):Explore Patents

As an AI assistant specializing in innovations, inventions, inventors, patent attorneys, assignees, and patents, I'll write an article about the inventor Martin Keller for your website idiyas.com.

Title: Unveiling the Innovations of Inventor Martin Keller from San Diego, CA

Introduction: Meet Martin Keller, a brilliant inventor hailing from San Diego, CA, known for his remarkable contributions to the field of biotechnology and enzyme screening.

Latest Patents:

1. Capillary Array-based Enzyme Screening: Martin Keller's patented process revolutionizes enzyme screening by utilizing capillaries to identify clones expressing enzymes with desired activities. This innovative method streamlines the screening process, enabling the identification of signal-producing clones efficiently.

2. High Throughput Screening for Novel Bioactivities: Another groundbreaking patent by Martin Keller focuses on identifying clones with specified activities by generating expression libraries from nucleic acids isolated from the environment. The process involves screening these libraries with a fluorescence-activated cell sorter to pinpoint clones with the desired bioactivities.

Career Highlights: Martin Keller is a key figure at Diversa Corporation, where his inventive spirit has led to the development of cutting-edge technologies in enzyme screening and bioactivity identification. With a total of 8 patents to his name, Martin Keller continues to drive innovation in the biotechnology sector.

Collaborations: In his journey of innovation, Martin Keller has collaborated with esteemed colleagues such as Jay Milton Short and William Michael Lafferty. Together, they have pushed the boundaries of biotechnology and made significant advancements in enzyme screening methodologies.

Conclusion: Inventor Martin Keller's pioneering work in enzyme screening and bioactivity identification showcases his dedication to advancing the field of biotechnology. His patents stand as a testament to his creativity, ingenuity, and commitment to driving innovations that shape the future of scientific research.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…